Analysis of 3-(acetylamino)-6-aminoacridine-derivatized oligosaccharides from recombinant monoclonal antibodies by liquid chromatography-mass spectrometry

Analytical Biochemistry

Volumn 390, Issue 2, 2009, Pages 209-211

  Clarke, Ambrose ^a   Harmon, Bryan ^a   DeFelippis, Michael R ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDES; LIQUIDS; MASS SPECTROMETRY; MONOCLONAL ANTIBODIES; OLIGOSACCHARIDES; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; POLYSACCHARIDES;

GLYCANS; LIQUID CHROMATOGRAPHY - MASS SPECTROMETRIES; N-GLYCANS; ON-LINE ELECTROSPRAY MASS SPECTROMETRY; RECOMBINANT MONOCLONAL ANTIBODY; RUNTIMES; SMALL PARTICLE SIZE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

HIGH PRESSURE LIQUID CHROMATOGRAPHY;

3 (ACETYLAMINO) 6 AMINOACRIDINE; GLYCAN DERIVATIVE; MONOCLONAL ANTIBODY; OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ARTICLE; CARBOHYDRATE ANALYSIS; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG DETERMINATION; ELECTROSPRAY MASS SPECTROMETRY; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 65849448756     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.04.022     Document Type: Article

References (9)

1. Aires da Silva F., Corte-Real S., and Goncalves J. Recombinant antibodies as therapeutic agents: pathways for modeling new biodrugs. Biodrugs 22 (2008) 301-314
2. Dingermann T. Recombinant therapeutic proteins: production platforms and challenges. Biotechnol. J. 3 (2008) 90-97
3. Jenkins N., Murphy L., and Tyther R. Post-translational modifications of recombinant proteins: significance for biopharmaceuticals. Mol. Biotechnol. 39 (2008) 113-118
4. Kamoda S., Ishikawa R., and Kakehi K. Capillary electrophoresis with laser-induced fluorescence detection for detailed studies on N-linked oligosaccharide profile of therapeutic recombinant monoclonal antibodies. J. Chromatogr. A 1133 (2006) 332-339
5. Jefferis R. Glycosylation of recombinant antibody therapeutics. Biotechnol. Prog. 21 (2005) 11-16
6. Chen X., and Flynn G.C. Analysis of N-glycans from recombinant immunoglobulin G by on-line reversed-phase high-performance liquid chromatography/mass spectrometry. Anal. Biochem. 370 (2007) 147-161
7. Omtvedt L.A., Royle L., Husby G., Sletten K., Radcliffe C.M., Harvey D.J., Dwek R.A., and Rudd P.M. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. Arthritis Rheum. 54 (2006) 3433-3440
8. Prater B.D., Connelly H.M., Qin Q., and Cockrill S.L. High-throughput immunoglobulin G N-glycan characterization using rapid resolution reverse-phase chromatography tandem mass spectrometry. Anal. Biochem. 385 (2009) 69-79
9. Pabst M., Kolarich D., Poltl G., Dalik T., Lubec G., Hofinger A., and Altmann F. Comparison of fluorescent labels for oligosaccharides and introduction of a new postlabeling purification method. Anal. Biochem. 384 (2008) 263-273